Revvity, Inc. Common Stock (RVTY)

Revvity’s first quarter results were well received by the market, as the company delivered stronger-than-expected organic growth and margins. Management attr...

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Life sciences company Revvity (NYSE:RVTY) fell short of the market’s revenue expectations in Q1 CY2026, but sales rose 9.3% year on year to $686.9 million. T...

What Happened? Shares of life sciences company Revvity (NYSE:RVTY) jumped 7.3% in the morning session after its first-quarter 2026 results surpassed Wall Str...

Revvity (RVTY) Q1 2026 Earnings Transcript

Life sciences company Revvity (NYSE:RVTY) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 7% year on year to $711.1 million....

Life sciences company Revvity (NYSE:RVTY) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 7% year on year to $711.1 milli...

Revvity, Inc. (NYSE: RVTY), today reported financial results for the first quarter ended April 5, 2026.

Life sciences company Revvity (NYSE:RVTY) will be reporting earnings this Tuesday before market hours. Here’s what you need to know. Revvity beat analysts’ r...

The Board of Directors of Revvity, Inc. (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on August 7, 2026 to all shareholders of record at the close of business on July 17, 2026.

Revvity currently trades at $94.26 per share and has shown little upside over the past six months, posting a small loss of 1.5%. The stock also fell short of...

What Happened? A number of stocks jumped in the afternoon session after the reopening of the Strait of Hormuz signaled a cooling of global logistics and ener...

Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences:

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...

Revvity, Inc. (NYSE: RVTY), today announced that it will release its first quarter 2026 financial results prior to market open on Tuesday, May 5, 2026. The Company will host a conference call the same day at 7:30 a.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Max Krakowiak, chief financial officer, will host the conference call.

Revvity, Inc. (NYSE: RVTY) announced that its Revvity Signals Software business is launching Signals BioDesignTM, a cloud-native molecular cloning solution that streamlines biologics research workflows. Built for biotech and pharma R&D teams, the platform simplifies complex cloning processes and enables scalable, collaborative development in a unified digital environment. It addresses the limitations of desktop tools and overly complex platforms by combining essential cloning methodologies with enterprise-grade collaboration.

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the research tools & consumables industry,...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.